Clinical Trial Update: ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for ANO-31905 in combination with chemotherapy for CLDN18.2-positive pancreatic cancer, listed as Phase 1/2 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ANO-31905

Snippet

Sponsor: Anova Innovation Limited | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING